Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Connection

Jenna Burton to Antineoplastic Agents

This is a "connection" page, showing publications Jenna Burton has written about Antineoplastic Agents.

 
Connection Strength
 
 
 
0.439
 
  1. Burton J, Khanna C. The role of clinical trials in veterinary oncology. Vet Clin North Am Small Anim Pract. 2014 Sep; 44(5):977-87.
    View in: PubMed
    Score: 0.189
  2. Burton JH, Mitchell L, Thamm DH, Dow SW, Biller BJ. Low-dose cyclophosphamide selectively decreases regulatory T cells and inhibits angiogenesis in dogs with soft tissue sarcoma. J Vet Intern Med. 2011 Jul-Aug; 25(4):920-6.
    View in: PubMed
    Score: 0.152
  3. Withers SS, York D, Johnson E, Al-Nadaf S, Skorupski KA, Rodriguez CO, Burton JH, Guerrero T, Sein K, Wittenburg L, Rebhun RB. In vitro and in vivo activity of liposome-encapsulated curcumin for naturally occurring canine cancers. Vet Comp Oncol. 2018 Dec; 16(4):571-579.
    View in: PubMed
    Score: 0.062
  4. Biller BJ, Guth A, Burton JH, Dow SW. Decreased ratio of CD8+ T cells to regulatory T cells associated with decreased survival in dogs with osteosarcoma. J Vet Intern Med. 2010 Sep-Oct; 24(5):1118-23.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)